Abeona Therapeutics, Inc. (ABEO)
4.49
-0.05
(-1.10%)
USD |
NASDAQ |
Mar 20, 10:26
Abeona Therapeutics Profit Margin (Quarterly) : -377.5% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -67.20K% |
| Plus Therapeutics, Inc. | -417.9% |
| Atossa Therapeutics, Inc. | -- |
| Cell Source, Inc. | -- |
| Kiora Pharmaceuticals, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 61.42% |
| Return on Assets | 39.25% |
| Return on Invested Capital | 50.87% |
| Gross Profit Margin (Quarterly) | 31.73% |
| Operating Margin (Quarterly) | -422.7% |
| Return on Net Operating Assets | 443.3% |